FDA NDC Directory · JSON-LD · Markdown

Oziltus

NDC 70121-2701 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namedenosumab-mobz
Labeler / ManufacturerAmneal Pharmaceuticals LLC
Marketing categoryBiologic License Application · App BLA761457
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsDENOSUMAB (70 mg/mL)
Marketing started20251223
Package count1

External sources

Source: openFDA. Public-domain (CC0).